The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study.

ABSTRACT:

SUBMITTER: Fei X 

PROVIDER: S-EPMC8506635 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature